JYQ-42 increased acetylation of the Sirt6 substrates histone H3K9, H3K18, and H3K56 in pancreatic cancer cell lines in a concentration-dependent manner, consistent with on-target Sirt6 inhibition [165]. The gene discussed is SIRT6; the disease is pancreatic neoplasm.